RxSight, Inc. Common Stock (RXST) Stock Price

RXSTStock
$4.51−46.82%52W
Market Cap$187.59M
P/E—
PEG Ratio—
Div yield—
Beta1.22

RXST Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-47.87%
Price vs S&P 500 (4W)-10.93%
VGM Score53.61

RXST Earnings Surprise History

QuarterReport dateEPS estimateEPS actualSurprise
Q2 2026-$0.19-$0.11+41.36%(+$0.08)
Q1 2026-$0.15-$0.19-28.38%(-$0.04)
Q4 2025-$0.20-$0.03+84.81%(+$0.17)
Q3 2025-$0.26-$0.04+84.63%(+$0.22)
Q2 2025-$0.11-$0.08+29.17%(+$0.03)

RXST Analyst Recommendations

Jun 2026
Jul 2026
Aug 2026
Sep 2026
2.60
2.60
2.60
2.60

Industry Peers — Ophthalmic Goods(8)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/E Ratio (Annual)ROE (TTM)Revenue Growth (5Y)Indicated Dividend Yield (Annual)Price
RXSTRxSight, Inc. Common Stock
BCD—-17.4%55.7%—$4.51
ALCAlcon Inc. Ordinary SharesCCC34.1x2.9%8.8%0.3%$66.18
COOThe Cooper Companies, Inc. Common StockBBC29.4x6.9%11.0%0.0%$57.94
BLCOBausch + Lomb CorporationBDB—-2.7%8.4%—$16.49
WRBYWarby Parker Inc.DBC1711.4x2.1%17.2%—$23.34
EYENational Vision Holdings, Inc. Common StockADC46.6x5.7%3.0%—$17.43
STAAStaar Surgical CoDBC—1.1%7.9%—$21.27
LUCYInnovative Eyewear, Inc. Common StockBAD—-88.9%113.5%—$0.79
LUCYWInnovative Eyewear, Inc. Series A Warrants 8/16/27——F————$0.03

About RxSight, Inc. Common Stock

RxSight Inc is a medical technology company specializing in light adjustable intraocular lenses for cataract surgery. Its proprietary technology allows surgeons to customize and optimize patient vision outcomes post-surgery, reducing the need for corrective eyewear and improving patient satisfaction. The company manufactures light adjustable lenses and related capital equipment for the ophthalmology market.